P. Newcomb

发表

Investigation of oesophageal adenocarcinoma for viral genomic sequences.

R. Morgan, R. Hardwick, D. Alderson, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.

N. Shepherd, R. Hardwick, D. Alderson, 1994, Gut.

Insulin‐like growth factor binding protein‐3 (IGFBP‐3) potentiates paclitaxel‐induced apoptosis in human breast cancer cells

J. Farndon, P. Newcomb, C. Perks, 2000, International journal of cancer.

c-erbB-2 overexpression in the dysplasia/carcinoma sequence of Barrett's oesophagus.

N. Shepherd, R. Hardwick, D. Alderson, 1995, Journal of clinical pathology.

Human papillomavirus and oesophageal squamous cell carcinoma in the UK.

R. Morgan, R. Hardwick, D. Alderson, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

A Comparison Study of Gastric Cancer Risk in Patients with Duodenal and Gastric Ulcer: Roles of Gastric Mucosal Histology and p53 Codon 72 Polymorphism

D. Alderson, P. Newcomb, A. Storey, 2004, Digestive Diseases and Sciences.

c-erbB2 overexpression in the dysplasia / carcinoma sequence of Barrett ' s oesophagus

N. Shepherd, R. Hardwick, D. Alderson, 2022 .

ect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells

P. Newcomb, C. Perks, J. Holly, 1999 .

Amplification of cyclin D1 and MDM-2 in oesophageal carcinoma.

R. Morgan, R. Hardwick, D. Alderson, 1999, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Effects of Cytokines on Suppression of Lymphocyte Proliferation by Dexamethasone1

Richard W. Lee, P. Newcomb, C. Dayan, 2009, The Journal of Immunology.

CD4+CD25int T Cells in Inflammatory Diseases Refractory to Treatment with Glucocorticoids1

A. Dick, P. Newcomb, C. Dayan, 2007, The Journal of Immunology.

Glucocorticoids Diseases Refractory to Treatment with T Cells in InflammatoryintCD 25 + CD 4 and

A. Dick, P. Newcomb, C. Dayan, 2007 .

Prolactin acts as a potent survival factor against C2-ceramide-induced apoptosis in human granulosa cells.

P. Newcomb, H. Mason, C. Perks, 2003, Human reproduction.

Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines

P. Newcomb, C. Perks, J. Holly, 1999, British Journal of Cancer.

Loss of heterozygosity at microsatellite marker sites for tumour suppressor genes in oesophageal adenocarcinoma.

R. Morgan, R. Hardwick, D. Alderson, 1998, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Increased, not decreased activation of the insulin-like growth factor (IGF) receptor signalling pathway during ceramide-induced apoptosis.

P. Newcomb, J. Tavaré, C. Stewart, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses.

P. Newcomb, J. Holly, P. Soothill, 1999, Placenta.

Multifaceted roles of TNF‐α in myoblast destruction: A multitude of signal transduction pathways

P. Newcomb, J. Holly, C. Stewart, 2004, Journal of cellular physiology.

Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma.

D. Alderson, P. Newcomb, A. Storey, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Insulin-like Growth Factor-binding Protein (IGFBP-3) Predisposes Breast Cancer Cells to Programmed Cell Death in a Non-IGF-dependent Manner*

P. Newcomb, J. Holly, C. Perks, 1997, The Journal of Biological Chemistry.

IGFBp‐3 prolongs the p53 response and enhances apoptosis following UV irradiation

D. Alderson, P. Newcomb, J. Holly, 2000, International journal of cancer.

Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells.

P. Newcomb, C. Perks, C M Perks, 1999, Journal of molecular endocrinology.

Prognostic Value of TP53 Codon 72 Polymorphism in Advanced Gastric Adenocarcinoma

D. Alderson, P. Newcomb, J. Holly, 2004, Clinical Cancer Research.

Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis.

R. Hardwick, D. Alderson, P. Newcomb, 1997, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.

C. Paraskeva, A. Williams, P. Newcomb, 2000, Cancer research.

Differential IGF‐independent effects of insulin‐like growth factor binding proteins (1–6) on apoptosis of breast epithelial cells

S. Bowen, P. Newcomb, J. Holly, 1999, Journal of cellular biochemistry.

Insulin-like growth factor binding protein-3: relationship to the development of gastric pre-malignancy and gastric adenocarcinoma (United Kingdom)

D. Alderson, P. Newcomb, A. Hollowood, 2004, Cancer Causes & Control.

Increased p 53-dependent Apoptosis by the Insulin-like Growth Factor Binding Protein IGFBP-3 in Human Colonic Adenoma-derived Cells 1

C. Paraskeva, P. Newcomb, J. Holly, 2000 .